NASDAQ:BTTX

Better Therapeutics Stock Forecast

etoro logo Buy BTTX
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of BTTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BTTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Better Therapeutics, Inc.
(Updated on Jul 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Apr 08, 2026

No changes to the price of Better Therapeutics, Inc. stock on the last trading day (Friday, 10th Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock has broken the narrow and horizontal trend up. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately. $0.00009999999999 is considered to be a "second chance" to hit a potential runner. It is, however, important that volume does follow the price as false breaks may appear and it may move back into the horizontal trend. Based on the rectangle-formation theory the stock is predicted to reach $0.0001 sometime during the next 3 months.

BTTX Signals & Forecast

The Better Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0001 and $0.00009999999974. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. The stock had a Golden Star Signal on Monday, June 29, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Monday, June 29, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Better Therapeutics, Inc. stock

Better Therapeutics, Inc. finds support from accumulated volume at $0.0001000000 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.000096 (-4.00%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (BTTX) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Better Therapeutics, Inc. to open at $0.0001, and during the day (based on 14 day Average True Range), to move between $0.00009999999989 and $0.0001, which gives a possible trading interval of +/-$0.00000000000023 (+/-0.00%) up or down from last closing price. If Better Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 0.00% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.0001000000, some $0.0000000000 (0.00%) from the current price of $0.0001, our system finds the risk reward attractive.

Is Better Therapeutics, Inc. stock A Buy?

Better Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $0.0001 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BTTX Performance

Trading levels for BTTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0001 -
R2 0.0001 -
R1 0.0001 -
Price 0.0001
S1 0.0001 -
S2 0.0001 -
S3 0.0001 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.0001
S1 0.0001000000 -0.000003%
S2 0 -
S3 0 -

FAQ

What is the symbol for Better Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Better Therapeutics, Inc. is BTTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Better Therapeutics, Inc. Stock?
Better Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Better Therapeutics, Inc. Stock?
Better Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Better Therapeutics, Inc. Stock.

What's the current price of Better Therapeutics, Inc. Stock?
As of the end of day on the Jul 10, 2026, the price of an Better Therapeutics, Inc. (BTTX) share was $0.0001.

What is the 52-week high and low for Better Therapeutics, Inc. Stock?
The 52-week high for Better Therapeutics, Inc. Stock is $0.0010 and the 52-week low is $0.0001000000.

What is the market capitalization of Better Therapeutics, Inc. Stock?
As of the Jul 10, 2026, the market capitalization of Better Therapeutics, Inc. is 5.452K.

When is the next earnings date for Better Therapeutics, Inc.?
The upcoming earnings date for Better Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT BETTER THERAPEUTICS, INC.
Better Therapeutics
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also in...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE